98%
921
2 minutes
20
Renal dysfunction (RD) is common in patients with heart failure with or without congenital heart disease, but the determinants of renal dysfunction are not well understood in children with heart failure. Low cardiac output is often discussed as a risk factor for RD.The purpose of this study was therefore to elucidate the relationship between renal function and hemodynamic parameters in children with heart failure. Children (age < 18, n = 3739) listed for HT in the PHTS database from 1993-2023 were included. Laboratory, clinical, hemodynamic, and demographic parameters were collected and analyzed for the study. RD was defined as eGFR less than 40 ml/min/1.73 m2 for patients younger than 2 years old, less than 60 ml/min/1.73 m2 for patients 2 years old and older. We assessed correlation between eGFR and hemodynamic parameters. Logistic regression was used to assess risk factors for renal dysfunction by etiologic cohort. The mean age was 7.2 ± 6.2 years, weight 27.78 ± 25.03 kg, male gender 58%, 39% with cardiomyopathy (CM) and 61% with congenital heart disease (CHD) including 21% with Fontan circulation. RD was present in 6% of the cohort.In CM cohort, high BMI (OR 1.057, 1.025-1.091), male gender (OR 2.08, 1.21-3.59), black race (OR 1.98, 1.17-3.36) and heart failure category of high cardiac index with high CVP compared to high cardiac index with low CVP (OR 2.34, 1.27-4.29) were significant predictors of renal dysfunction.In Fontan cohort, only BMI (OR 1.08, CI 1.023-1.134) was associated with renal dysfunction while none of the hemodynamic parameters predicted RD in CHD cohort.Lastly, RD at listing (OR 2.82, CI 1.50-5.28), weight at transplant (OR 1.00, CI 1.00-1.01), post-transplant mechanical circulatory support (OR 2.55, CI 1.04-6.26), and post-transplant dialysis (2.74, CI 1.106.84) were associated with RD at one-year post-transplant for the overall cohort. The relationship between various clinical and hemodynamic factors and renal dysfunction is complex in children with heart failure. Further, the study continued to show persistent impact of renal dysfunction at listing on post-transplant renal function. Improving understanding modifiable risk factors by type of heart disease as well as role of newer heart failure therapies is critical in reducing this significant morbidity.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00246-025-03956-9 | DOI Listing |
Eur J Heart Fail
September 2025
Cardiology Department, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Aims: There is a lack of data from randomized clinical trials comparing treatment outcomes between conduction system pacing (CSP) modalities and biventricular pacing (BVP) in symptomatic patients with refractory atrial fibrillation (AF) scheduled for atrioventricular node ablation (AVNA). The CONDUCT-AF investigates whether CSP is non-inferior to BVP in improving left ventricular ejection fraction (LVEF) and clinical outcomes in heart failure (HF) patients with symptomatic AF undergoing AVNA.
Methods: This study is an investigator-initiated, prospective, randomized, multicentre clinical trial conducted across 10 European centres, enrolling 82 patients with symptomatic AF, HF with reduced LVEF, and narrow QRS.
JAMA Netw Open
September 2025
Division of Cardiology, Department of Internal Medicine, New Taipei Municipal TuCheng Hospital, New Taipei, Taiwan.
Importance: The cardiovascular benefits of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may vary by body mass index (BMI), but evidence on BMI-specific outcomes remains limited.
Objective: To investigate the associations of GLP-1 RA use with cardiovascular and kidney outcomes across BMI categories in patients with type 2 diabetes.
Design, Setting, And Participants: This retrospective cohort study used the Chang Gung Research Database, a clinical dataset covering multiple hospitals in Taiwan.
Curr Opin Cardiol
August 2025
National Heart and Lung Institute, Imperial College London.
Purpose Of Review: Symptom relief is now recognized as the primary remit of percutaneous coronary intervention (PCI) in patients with stable coronary artery disease. The relationship between the nature of angina symptoms and the likelihood of successful symptom relief from PCI had not been systematically studied until recently.
Recent Findings: The ORBITA-2 symptom-stratified analysis found that while the severity and nature of symptoms were poorly associated with the severity of coronary disease, the nature of the symptoms powerfully predicted the efficacy of PCI in relieving angina.
Cardiol Rev
September 2025
From the Department of General Medicine, J.S.S. Medical College, JSS Academy of Higher Education and Research, Mysuru, India.
Heart failure with preserved ejection fraction (HFpEF) accounts for nearly half of all heart failure cases and is increasing in prevalence due to aging populations and comorbidities such as hypertension and diabetes. While echocardiography remains the diagnostic cornerstone, many patients with preserved ejection fraction present with nonspecific symptoms and ambiguous diastolic indices, leading to diagnostic uncertainty and therapeutic delay. Arterial stiffness-quantified by pulse wave velocity, augmentation index, and cardio-ankle vascular index)-is emerging as a key contributor to HFpEF pathophysiology.
View Article and Find Full Text PDFCardiovasc Res
September 2025
Department of Advanced Medical and Surgical Sciences, University of Campania 'Luigi Vanvitelli', Piazza Miraglia, 2, Naples 80138, Italy.